Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: JAMA Intern Med. 2015 Apr 1;175(4):531–539. doi: 10.1001/jamainternmed.2014.8063

Figure 3. Kaplan-Meier Estimates of Post-FMP Persistence of Frequent VMS by Menopausal Transition Stage at First VMS Report and by Race/Ethnicity.

Figure 3

A, By menopausal transition stage at first VMS report. B, By race/ethnicity. FMP indicates final menstrual period; VMS, vasomotor symptoms. Menopausal transition stage at first VMS report is missing for 2 participants. Median duration for each group is calculated as the value on the x-axis corresponding to the intersection of the dashed horizontal line (50%) with the group’s survival curve.

HHS Vulnerability Disclosure